The presence of beta-amyloid deposits in the brain significantly limits the effectiveness of cognitive training in healthy older adults, according to new research presented at the 2024 Society of Nuclear Medicine and Molecular ...
Jun 10, 2024
0
0
Calcific aortic valve disease (CAVD) is the major heart valve disease that afflicts nearly 10 million patients globally with an annual mortality exceeding 100,000, and the numbers continue to rise.
Jun 5, 2024
0
0
Columbia researchers have discovered a genetic variant that reduces the odds of developing Alzheimer's disease by up to 70% and may be protecting thousands of people in the United States from the disease. The study, "Rare ...
Apr 10, 2024
0
65
In people with Alzheimer's disease (AD), the epigenetic regulator HDAC6 (histone deacetylase 6), which controls many biological processes, is significantly overexpressed in the brain.
Nov 27, 2023
0
36
Early results from PharmaKure, a pharmaceutical company spun out from The University of Manchester, shows a novel whole blood test developed by the company is able to quantify Alzheimer's disease biomarkers.
Oct 17, 2023
0
0
Amyloid deposition is a hallmark of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD). The deposition process is described as a sigmoidal curve in which the misfolded proteins assemble ...
Aug 2, 2023
0
13
A novel vaccine that targets inflamed brain cells associated with Alzheimer's disease may hold the key to potentially preventing or modifying the course of the disease, according to preliminary research presented at the American ...
Jul 30, 2023
3
17
Three men who had heart failure caused by the build-up of sticky, toxic proteins are now free of symptoms after their condition spontaneously reversed in an unprecedented case described by a team at UCL (University College ...
Jun 7, 2023
0
952
A novel nuclear medicine imaging protocol can take the place of two separate imaging scans for the evaluation of brain changes linked to cognitive impairment, cutting costs and radiation exposure for patients as well as providing ...
Feb 8, 2023
0
15
Lecanemab: It's an experimental medication that's been shown in trials to slow cognitive decline in people with Alzheimer's disease.
Jan 6, 2023
0
6
